The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?

[1]  A. Quaas,et al.  Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. , 2007, Gastroenterology.

[2]  A. Rodrigo,et al.  Viral quasi-species evolution during hepatitis Be antigen seroconversion. , 2007, Gastroenterology.

[3]  T. Liang,et al.  Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. , 2007, Gastroenterology.

[4]  A. Lok,et al.  Navigating the maze of hepatitis B treatments. , 2007, Gastroenterology.

[5]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[6]  B. McMahon,et al.  Chronic hepatitis B. , 2002, The New England journal of medicine.

[7]  J. Koskinas,et al.  Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.

[8]  P. Schirmacher,et al.  Peginterferon alpha‐2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B , 2006, Hepatology.

[9]  S. Bowden.  Serological and molecular diagnosis. , 2006, Seminars in liver disease.

[10]  F. Chisari,et al.  Stealth and Cunning: Hepatitis B and Hepatitis C Viruses , 2005, Journal of Virology.

[11]  V. Wong,et al.  Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. , 2005, Gastroenterology.

[12]  D. Fong,et al.  Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. , 2005, Blood.

[13]  M. Yuen,et al.  Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients , 2004, Hepatology.

[14]  T. Luedde,et al.  Basal Core Promoter and Precore Mutations in the Hepatitis B Virus Genome Enhance Replication Efficacy of Lamivudine-Resistant Mutants , 2004, Journal of Virology.

[15]  C. Gibbs,et al.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.

[16]  F. Chisari,et al.  Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site , 2001, Journal of Virology.

[17]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[18]  C. Hannoun,et al.  Long-term mutation rates in the hepatitis B virus genome. , 2000, The Journal of general virology.

[19]  F. Chisari,et al.  La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA , 1999, Journal of Virology.

[20]  F. Chisari,et al.  Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice , 1999, Journal of Virology.

[21]  A. Lok,et al.  High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. , 1997, Journal of hepatology.

[22]  H. Bozkaya,et al.  High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection , 1996, Hepatology.

[23]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[24]  K. Koike,et al.  The serology of chronic hepatitis B infection revisited. , 1993, The Journal of clinical investigation.

[25]  A. Lok,et al.  Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. , 1990, Journal of hepatology.

[26]  H. Thomas,et al.  Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum , 1985, Hepatology.